FEATURED ARTICLE

 

Frontier Pharma: Neurodegenerative Diseases - Protein Misfolding Targets and Neuromodulators Dominate the First-in-Class Pipeline and Lead the Way as Potential Disease-Modifying Therapies in AD and PD

PR Newswire  2017-12-01 03:27:00

NEW YORK, Nov. 30, 2017 /PRNewswire/ -- Frontier Pharma: Neurodegenerative Diseases - Protein Misfolding Targets and Neuromodulators Dominate the First-in-Class Pipeline and Lead the Way as Potential Disease-Modifying Therapies in AD and PDRead the full report:...

Full Story »

Comments

No Comments
Your name: *
Email:
Comment: *
 
Share
submit to reddit